Drugs / TK1258
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00831792 | Apr 2010 → Jun 2017 | prostate cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TK1258 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00831792 ↗ |
| Route | Oral | “4 capsules (100 mg/capsules) of TKI 258 by mouth once daily” NCT00831792 ↗ |